Suchergebnisse - (Person:"Guo, Ensong")

PubPharm (20)

11

Role of Dicer as a prognostic predictor for survival in cancer patients : a systematic review with a meta-analysis

enthalten in: Oncotarget | 2016

von Shan, W. | Sun, C. | Zhou, B. | +9

12

Blockage of glutaminolysis enhances the sensitivity of ovarian cancer cells to PI3K/mTOR inhibition involvement of STAT3 signaling

enthalten in: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine | 2016

von Guo, L. | Zhou, B. | Liu, Z. | +7

13

KCNN4 and S100A14 act as predictors of recurrence in optimally debulked patients with serous ovarian cancer

enthalten in: Oncotarget | 2016

von Zhao, H. | Guo, E. | Hu, T. | +16

14

Cisplatin-induced CCL5 secretion from CAFs promotes cisplatin-resistance in ovarian cancer via regulation of the STAT3 and PI3K/Akt signaling pathways

enthalten in: International journal of oncology | 2016

von Zhou, B. | Sun, C. | Li, N. | +10

15

Blockage of glutaminolysis enhances the sensitivity of ovarian cancer cells to PI3K/mTOR inhibition involvement of STAT3 signaling

enthalten in: Tumor biology | 2016

von Guo, L. | Zhou, B. | Liu, Z. | +7

16

Blockage of glutaminolysis enhances the sensitivity of ovarian cancer cells to PI3K/mTOR inhibition involvement of STAT3 signaling

enthalten in: Tumor biology | 2016

von Guo, L. | Zhou, B. | Liu, Z. | +7

17

Blockage of glutaminolysis enhances the sensitivity of ovarian cancer cells to PI3K/mTOR inhibition involvement of STAT3 signaling

enthalten in: Tumor biology | 2016

von Guo, L. | Zhou, B. | Liu, Z. | +7

18

HSP27 Knockdown Increases Cytoplasmic p21 and Cisplatin Sensitivity in Ovarian Carcinoma Cells

enthalten in: Oncology research | 2016

von Lu, H. | Sun, C. | Zhou, T. | +11

19

HSP27 Knockdown Increases Cytoplasmic p21 and Cisplatin Sensitivity in Ovarian Carcinoma Cells

enthalten in: Oncology research | 2016

von Lu, H. | Sun, C. | Zhou, T. | +11

20

Cisplatin-induced CCL5 secretion from CAFs promotes cisplatin-resistance in ovarian cancer via regulation of the STAT3 and PI3K/Akt signaling pathways

enthalten in: International journal of oncology | 2016

von ZHOU, B. | SUN, C. | LI, N. | +10